Literature DB >> 30404793

Infection and Functional Modulation of Human Monocytes and Macrophages by Varicella-Zoster Virus.

Megan Steain1, Barry Slobedman1, Allison Abendroth2, Jarrod J Kennedy1.   

Abstract

Varicella-zoster virus (VZV) is associated with viremia during primary infection that is presumed to stem from infection of circulating immune cells. While VZV has been shown to be capable of infecting a number of different subsets of circulating immune cells, such as T cells, dendritic cells, and NK cells, less is known about the interaction between VZV and monocytes. Here, we demonstrate that blood-derived human monocytes are permissive to VZV replication in vitro VZV-infected monocytes exhibited each temporal class of VZV gene expression, as evidenced by immunofluorescent staining. VZV virions were observed on the cell surface and viral nucleocapsids were observed in the nucleus of VZV-infected monocytes by scanning electron microscopy. In addition, VZV-infected monocytes were able to transfer infectious virus to human fibroblasts. Infected monocytes displayed impaired dextran-mediated endocytosis, and cell surface immunophenotyping revealed the downregulation of CD14, HLA-DR, CD11b, and the macrophage colony-stimulating factor (M-CSF) receptor. Analysis of the impact of VZV infection on M-CSF-stimulated monocyte-to-macrophage differentiation demonstrated the loss of cell viability, indicating that VZV-infected monocytes were unable to differentiate into viable macrophages. In contrast, macrophages differentiated from monocytes prior to exposure to VZV were highly permissive to infection. This study defines the permissiveness of these myeloid cell types to productive VZV infection and identifies the functional impairment of VZV-infected monocytes.IMPORTANCE Primary VZV infection results in the widespread dissemination of the virus throughout the host. Viral transportation is known to be directly influenced by susceptible immune cells in the circulation. Moreover, infection of immune cells by VZV results in attenuation of the antiviral mechanisms used to control infection and limit spread. Here, we provide evidence that human monocytes, which are highly abundant in the circulation, are permissive to productive VZV infection. Furthermore, monocyte-derived macrophages were also highly permissive to VZV infection, although VZV-infected monocytes were unable to differentiate into macrophages. Exploring the relationships between VZV and permissive immune cells, such as human monocytes and macrophages, elucidates novel immune evasion strategies and provides further insight into the control that VZV has over the immune system.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  varicella-zoster virus

Mesh:

Substances:

Year:  2019        PMID: 30404793      PMCID: PMC6340020          DOI: 10.1128/JVI.01887-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.

Authors:  Ann M Arvin; Jennifer F Moffat; Marvin Sommer; Stefan Oliver; Xibing Che; Susan Vleck; Leigh Zerboni; Chia-Chi Ku
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

2.  Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers.

Authors:  Chia-Chi Ku; Jorge A Padilla; Charles Grose; Eugene C Butcher; Ann M Arvin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  IFN-α production by human mononuclear cells infected with varicella-zoster virus through TLR9-dependent and -independent pathways.

Authors:  Hong-Ren Yu; Hsin-Chun Huang; Ho-Chang Kuo; Jiunn-Ming Sheen; Chia-Yo Ou; Te-Yao Hsu; Kuender D Yang
Journal:  Cell Mol Immunol       Date:  2011-02-14       Impact factor: 11.530

4.  Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability.

Authors:  Qingxue Li; Mir A Ali; Kening Wang; Dean Sayre; Frederick G Hamel; Elizabeth R Fischer; Robert G Bennett; Jeffrey I Cohen
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

5.  CD14 is a coreceptor of Toll-like receptors 7 and 9.

Authors:  Christoph L Baumann; Irene M Aspalter; Omar Sharif; Andreas Pichlmair; Stephan Blüml; Florian Grebien; Manuela Bruckner; Pawel Pasierbek; Karin Aumayr; Melanie Planyavsky; Keiryn L Bennett; Jacques Colinge; Sylvia Knapp; Giulio Superti-Furga
Journal:  J Exp Med       Date:  2010-11-15       Impact factor: 14.307

6.  Regulated nuclear localization of the varicella-zoster virus major regulatory protein, IE62.

Authors:  P R Kinchington; S E Turse
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

7.  Viremia in acute herpes zoster.

Authors:  Anita K Satyaprakash; Anne Marie Tremaine; Arwen A Stelter; Rosella Creed; Parisa Ravanfar; Natalia Mendoza; Satish K Mehta; Peter L Rady; Duane L Pierson; Stephen K Tyring
Journal:  J Infect Dis       Date:  2009-07-01       Impact factor: 5.226

8.  Varicella zoster virus productively infects human natural killer cells and manipulates phenotype.

Authors:  Tessa Mollie Campbell; Brian Patrick McSharry; Megan Steain; Thomas Myles Ashhurst; Barry Slobedman; Allison Abendroth
Journal:  PLoS Pathog       Date:  2018-04-30       Impact factor: 6.823

9.  Study of transforming growth factor alpha for the maintenance of human embryonic stem cells.

Authors:  Andy C H Chen; Y L Lee; Denise Y C Hou; S W Fong; Qian Peng; Ronald T K Pang; Phillip C N Chiu; P C Ho; Kai-Fai Lee; William S B Yeung
Journal:  Cell Tissue Res       Date:  2012-08-03       Impact factor: 5.249

10.  In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency.

Authors:  Tomohiko Sadaoka; Daniel P Depledge; Labchan Rajbhandari; Arun Venkatesan; Judith Breuer; Jeffrey I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-12       Impact factor: 12.779

View more
  9 in total

1.  The frequency of interleukin-1β-producing monocytes is significantly associated with varicella-zoster responses of nursing home residents.

Authors:  E Picard; D M E Bowdish; J E McElhaney; G Pawelec; M Loeb; C P Verschoor
Journal:  Clin Exp Immunol       Date:  2021-04-04       Impact factor: 5.732

Review 2.  Modeling Varicella Zoster Virus Persistence and Reactivation - Closer to Resolving a Perplexing Persistent State.

Authors:  Lillian Laemmle; Ronald S Goldstein; Paul R Kinchington
Journal:  Front Microbiol       Date:  2019-07-24       Impact factor: 5.640

3.  Virology Downunder, a meeting commentary from the 2019 Lorne Infection and Immunity Conference, Australia.

Authors:  Gregor Ebert; Prasad N Paradkar; Sarah L Londrigan
Journal:  Virol J       Date:  2019-09-02       Impact factor: 4.099

Review 4.  Manipulation of the Innate Immune Response by Varicella Zoster Virus.

Authors:  Chelsea Gerada; Tessa M Campbell; Jarrod J Kennedy; Brian P McSharry; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

5.  Opposing roles for sMAdCAM and IL-15 in COVID-19 associated cellular immune pathology.

Authors:  Amit Kumar Singh; Nandini Kasarpalkar; Shilpa Bhowmick; Gaurav Paradkar; Mayur Talreja; Karan Shah; Abhishek Tiwari; Harsha Palav; Snehal Kaginkar; Rajiv Kulkarni; Ashwini Patil; Varsha Kalsurkar; Sachee Agrawal; Jayanthi Shastri; Rajesh Dere; Ramesh Bharmal; Smita D Mahale; Vikrant M Bhor; Vainav Patel
Journal:  J Leukoc Biol       Date:  2022-01-24       Impact factor: 6.011

6.  Varicella-Zoster virus ORF9 is an antagonist of the DNA sensor cGAS.

Authors:  Jonny Hertzog; Wen Zhou; Gerissa Fowler; Rachel E Rigby; Anne Bridgeman; Henry Tw Blest; Chiara Cursi; Lise Chauveau; Tamara Davenne; Benjamin E Warner; Paul R Kinchington; Philip J Kranzusch; Jan Rehwinkel
Journal:  EMBO J       Date:  2022-06-07       Impact factor: 14.012

Review 7.  Th1 regulatory events by infectious pathogens, herpes zoster and herpes simplex viruses: prospects for therapeutic options for atopic eczema.

Authors:  Yasuhiro Horiuchi
Journal:  Postepy Dermatol Alergol       Date:  2022-09-01       Impact factor: 1.664

8.  Clinical characteristics and outcomes of patients with Herpes Zoster Infection in the context of SARS-CoV-2 infection. A case report and a systematic review.

Authors:  Pawan Kumar Thada; Fateen Ata; Muhammad Ali; Mohammad Nasser Affas; Jenish Bhandari; Sarosh Sarwar; Bilal Ahmed; Hassan Choudry
Journal:  Qatar Med J       Date:  2022-09-01

9.  Quantitative proteomics of small numbers of closely-related cells: Selection of the optimal method for a clinical setting.

Authors:  Kyra van der Pan; Sara Kassem; Indu Khatri; Arnoud H de Ru; George M C Janssen; Rayman T N Tjokrodirijo; Fadi Al Makindji; Eftychia Stavrakaki; Anniek L de Jager; Brigitta A E Naber; Inge F de Laat; Alesha Louis; Wouter B L van den Bossche; Lisette B Vogelezang; Rutger K Balvers; Martine L M Lamfers; Peter A van Veelen; Alberto Orfao; Jacques J M van Dongen; Cristina Teodosio; Paula Díez
Journal:  Front Med (Lausanne)       Date:  2022-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.